Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Acorda Drug Helps Stroke Patients Walk Better
TheStreet.com
Monday, April 15, 2013 - 8:50am
tags:
Acorda, AMPYRA, stroke
Royalty Pharma sweetens offer for Elan
Reuters
Monday, April 15, 2013 - 8:48am
tags:
Elan, M&A, Royalty Pharma
Data may support efficacy of COPD combo therapy, FDA document says
The Fly on the Wall
Monday, April 15, 2013 - 8:46am
tags:
FDA, COPD, GSK, Theravance, Breo Ellipta
Abbott Labs recalls blood glucose meters over inaccurate memory for dangerously high readings
Yahoo/AP
Monday, April 15, 2013 - 8:45am
tags:
Abbott Laboratories, recalls, blood glucose monitoring, diabetes
Pfizer's New Breast Cancer Drug Could Be A Game Changer
Seeking Alpha
Monday, April 15, 2013 - 8:40am
tags:
Pfizer, breast cancer, palbociclib, AstraZeneca, Novartis, GSK, Bristol-Myers Squibb
Sanofi Won’t Chase Alzheimer’s Therapies, Viehbacher Says
Bloomberg
Monday, April 15, 2013 - 8:39am
tags:
Chris Viehbacher, Sanofi, Alzheimer's disease
Shasun Pharma in licensing pact with Debiopharm Group
MoneyControl, India
Sunday, April 14, 2013 - 12:23pm
tags:
Shasun Pharma, Debiopharm
China Biotech In Review: Lilly Invests $100 Million In China Animal Healthcare
Seeking Alpha
Sunday, April 14, 2013 - 12:21pm
tags:
OriGene Technologies, Eli Lilly, Tong Ren Tang Technologies, Eddingpharm
Hard Times at Eli Lilly
Motley Fool
Sunday, April 14, 2013 - 12:20pm
tags:
Eli Lilly
Pfizer’s Big Breakthrough for Breast Cancer
Wall Street Cheat Street
Sunday, April 14, 2013 - 12:19pm
tags:
Pfizer, palbociclib, breast cancer
This Week in Biotech
Motley Fool
Sunday, April 14, 2013 - 12:18pm
tags:
Pfizer, Novartis, Acadia, Astex, AcelRx, Synergy Pharmaceuticals
ImmunoGen Offers New Hope For Treatment Of Subtypes Of Squamous Cell Carcinomas And Other Cancers
Seeking Alpha
Sunday, April 14, 2013 - 12:16pm
tags:
non-small cell lung cancer, Immunogen, IMGN289, head and neck cancer
An Obesity Drugmaker's Critical Coming Weeks
Motley Fool
Sunday, April 14, 2013 - 12:14pm
tags:
Arena, Qsymia, obesity, weight loss
2 Hot Biotech Stocks to Buy Now
Motley Fool
Sunday, April 14, 2013 - 12:13pm
tags:
Biogen Idec, Celgene
Actavis agrees with Valeant's subsidiary to introduce generic versions of Ziana, Zyclara
Pharmabiz
Saturday, April 13, 2013 - 12:27pm
tags:
Valeant Pharmaceuticals, generics, Ziana, Zyclara, Medicis
3 Pharmaceutical Stocks to Sell Now
InvestorPlace
Saturday, April 13, 2013 - 12:24pm
tags:
Vivus, Cempra, Corcept Therapeutics
Isis Pharmaceuticals - Antisense Making Sense
Seeking Alpha
Saturday, April 13, 2013 - 12:22pm
tags:
Isis Pharmaceuticals, RNA
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Saturday, April 13, 2013 - 12:20pm
tags:
JNJ, Bristol-Myers Squibb, Watson Pharmaceuticals, Repros Therapeutics
Obama budget is a disaster for drugmakers
Washington Post
Saturday, April 13, 2013 - 12:19pm
tags:
Lupin Launches its Oral Contraceptive Daysee Tablets in the US Market; Generic of Seasonique Tablets
Sacramento Bee, CA
Saturday, April 13, 2013 - 12:16pm
tags:
Daysee, Seasonique, generics, Lupin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.